United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017

SKU ID : QYR-

Publishing Date : 01-Mar-2017

No. of pages : 109

PRICE
3800
7600


  • Notes:
    Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH)
    Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH)

    This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Boehringer Ingelheim?
    Cerenis Therapeutics?
    Connexios Life Sciences?
    Genfit?
    Islet Sciences?
    Nimbus Therapeutics?
    Verva Pharmaceuticals?
    Viking Therapeutics?
    Astazeneca Plc
    Galmed Pharmaceuticals Ltd.
    GENFIT SA
    Gilead Science
    Novo Nordisk
    Immuron Ltd
    Intercepts Pharmaceuticals
    Enzo Biochem, Inc
    Tobira Therapeutics, Inc.

    Market Segment by States, covering
    California
    Texas
    New York
    Florida
    Illinois
    Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Weight Loss Treatment
    Insulin-Sensitizing Agents
    Lipid-Lowering Drugs
    Antioxidants
    Other Agents
    Split by applications, this report focuses on sales, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in each application, can be divided into
    Phase I
    Phase II
    Phase III
    Clinical Trials

    Detailed TOC of United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017

    Table of Contents

    United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017
    1 Nonalcoholic Steatohepatitis (NASH) Overview
    1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
    1.2 Classification of Nonalcoholic Steatohepatitis (NASH)
    1.2.1 Weight Loss Treatment
    1.2.2 Insulin-Sensitizing Agents
    1.2.3 Lipid-Lowering Drugs
    1.2.4 Antioxidants
    1.2.5 Other Agents
    1.3 Application of Nonalcoholic Steatohepatitis (NASH)
    1.3.1 Phase I
    1.3.2 Phase II
    1.3.3 Phase III
    1.3.4 Clinical Trials
    1.4 United States Market Size Sales (Volume) and Revenue (Value) of Nonalcoholic Steatohepatitis (NASH) (2012-2022)
    1.4.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2022)
    1.4.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2022)

    2 United States Nonalcoholic Steatohepatitis (NASH) Competition by Manufacturers
    2.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States Nonalcoholic Steatohepatitis (NASH) Average Price by Manufactures (2015 and 2016)
    2.4 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
    2.4.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
    2.4.2 Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 and Top 5 Manufacturers
    2.4.3 Mergers & Acquisitions, Expansion

    3 United States Nonalcoholic Steatohepatitis (NASH) Sales (Volume) and Revenue (Value) by States (2012-2017)
    3.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by States (2012-2017)
    3.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by States (2012-2017)
    3.3 United States Nonalcoholic Steatohepatitis (NASH) Price by States (2012-2017)

    4 United States Nonalcoholic Steatohepatitis (NASH) Sales (Volume) and Revenue (Value) by Type (2012-2017)
    4.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type (2012-2017)
    4.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
    4.3 United States Nonalcoholic Steatohepatitis (NASH) Price by Type (2012-2017)
    4.4 United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2012-2017)

    5 United States Nonalcoholic Steatohepatitis (NASH) Sales (Volume) by Application (2012-2017)
    5.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application (2012-2017)
    5.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

    6 United States Nonalcoholic Steatohepatitis (NASH) Manufacturers Profiles/Analysis
    6.1 Boehringer Ingelheim?
    6.1.1 Company Basic Information, Manufacturing Base and Competitors
    6.1.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
    6.1.3 Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.1.4 Main Business/Business Overview
    6.2 Cerenis Therapeutics?
    6.2.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
    6.2.3 Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.2.4 Main Business/Business Overview
    6.3 Connexios Life Sciences?
    6.3.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
    6.3.3 Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.3.4 Main Business/Business Overview
    6.4 Genfit?
    6.4.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
    6.4.3 Genfit? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.4.4 Main Business/Business Overview
    6.5 Islet Sciences?
    6.5.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
    6.5.3 Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.5.4 Main Business/Business Overview
    6.6 Nimbus Therapeutics?
    6.6.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
    6.6.3 Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.6.4 Main Business/Business Overview
    6.7 Verva Pharmaceuticals?
    6.7.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
    6.7.3 Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.7.4 Main Business/Business Overview
    6.8 Viking Therapeutics?
    6.8.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
    6.8.3 Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.8.4 Main Business/Business Overview
    6.9 Astazeneca Plc
    6.9.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
    6.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.9.4 Main Business/Business Overview
    6.10 Galmed Pharmaceuticals Ltd.
    6.10.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
    6.10.3 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    6.10.4 Main Business/Business Overview
    6.11 GENFIT SA
    6.12 Gilead Science
    6.13 Novo Nordisk
    6.14 Immuron Ltd
    6.15 Intercepts Pharmaceuticals
    6.16 Enzo Biochem, Inc
    6.17 Tobira Therapeutics, Inc.

    7 Nonalcoholic Steatohepatitis (NASH) Manufacturing Cost Analysis
    7.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
    7.1.1 Key Raw Materials
    7.1.2 Price Trend of Key Raw Materials
    7.1.3 Key Suppliers of Raw Materials
    7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.2.1 Raw Materials
    7.2.2 Labor Cost
    7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

    8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2015
    8.4 Downstream Buyers

    9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
    9.1.1 Direct Marketing
    9.1.2 Indirect Marketing
    9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
    9.2.1 Pricing Strategy
    9.2.2 Brand Strategy
    9.2.3 Target Client
    9.3 Distributors/Traders List

    10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
    10.1.1 Substitutes Threat
    10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

    11 United States Nonalcoholic Steatohepatitis (NASH) Market Forecast (2017-2022)
    11.1 United States Nonalcoholic Steatohepatitis (NASH) Sales, Revenue Forecast (2017-2022)
    11.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type (2017-2022)
    11.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application (2017-2022)
    11.4 Nonalcoholic Steatohepatitis (NASH) Price Forecast (2017-2022)

    12 Research Findings and Conclusion

    13 Appendix
    Methodology
    Analyst Introduction
    Data Source

    List of Figures, Tables and Charts Available in United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017

    List of Tables and Figures

    Figure Picture of Nonalcoholic Steatohepatitis (NASH)
    Table Classification of Nonalcoholic Steatohepatitis (NASH)
    Figure United States Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2015
    Figure Weight Loss Treatment Picture
    Figure Insulin-Sensitizing Agents Picture
    Figure Lipid-Lowering Drugs Picture
    Figure Antioxidants Picture
    Figure Other Agents Picture
    Table Application of Nonalcoholic Steatohepatitis (NASH)
    Figure United States Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application in 2015
    Figure Phase I Examples
    Figure Phase II Examples
    Figure Phase III Examples
    Figure Clinical Trials Examples
    Figure United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2022)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2022)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales of Key Manufacturers (2015 and 2016)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers (2015 and 2016)
    Figure 2015 Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers
    Figure 2016 Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers
    Table United States Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2015 and 2016)
    Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers
    Table 2016 United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers
    Table United States Market Nonalcoholic Steatohepatitis (NASH) Average Price of Key Manufacturers (2015 and 2016)
    Figure United States Market Nonalcoholic Steatohepatitis (NASH) Average Price of Key Manufacturers in 2015
    Figure Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 Manufacturers
    Figure Nonalcoholic Steatohepatitis (NASH) Market Share of Top 5 Manufacturers
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales by States (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by States (2012-2017)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by States in 2015
    Table United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by States (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by States (2012-2017)
    Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by States (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Price by States (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales by Type (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Type (2012-2017)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type in 2015
    Table United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Price by Type (2012-2017)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales by Application (2012-2017)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2012-2017)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2015
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
    Table Boehringer Ingelheim? Basic Information List
    Table Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Figure Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Cerenis Therapeutics? Basic Information List
    Table Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Connexios Life Sciences? Basic Information List
    Table Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Genfit? Basic Information List
    Table Genfit? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Genfit? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Islet Sciences? Basic Information List
    Table Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Nimbus Therapeutics? Basic Information List
    Table Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Verva Pharmaceuticals? Basic Information List
    Table Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Viking Therapeutics? Basic Information List
    Table Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Astazeneca Plc Basic Information List
    Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table Galmed Pharmaceuticals Ltd. Basic Information List
    Table Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
    Table GENFIT SA Basic Information List
    Table Gilead Science Basic Information List
    Table Novo Nordisk Basic Information List
    Table Immuron Ltd Basic Information List
    Table Intercepts Pharmaceuticals Basic Information List
    Table Enzo Biochem, Inc Basic Information List
    Table Tobira Therapeutics, Inc. Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (NASH)
    Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
    Figure Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
    Table Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2015
    Table Major Buyers of Nonalcoholic Steatohepatitis (NASH)
    Table Distributors/Traders List
    Figure United States Nonalcoholic Steatohepatitis (NASH) Production and Growth Rate Forecast (2017-2022)
    Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2017-2022)
    Table United States Nonalcoholic Steatohepatitis (NASH) Production Forecast by Type (2017-2022)
    Table United States Nonalcoholic Steatohepatitis (NASH) Consumption Forecast by Application (2017-2022)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Forecast by States (2017-2022)
    Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by States (2017-2022)

    Latest REPORTS

    Related REPORTS